In vitro production
The entomopathogenic virus LdMNPV for example is highly effective against gypsy moth, Lymantria dispar. This pest causes losses in forestry in different climatic zones.
So far a LdMNPV production is possible in vivo using the pest insect as host to meet the market requirements. BIOCOMES will focus on the development of the in vitro production of this LdMNPV virus to allow a significant further up-scaling of the production. The in vitro production of the LdMNPV agent will be developed in cell cultures to replace in vivo production depending on insect rearing. The BIOCOMES biological control agent that will be developed against gypsy moth will include this pilot technology.
Current stage of the Biological Control Agent
Want to know more about this project? Feel free to contact us!Contact us
Subscribe to our newsletter
The BIOCOMES project has come to an end. The last newsletter has been sent.
Four years of public-private cooperation results in successful development of new biological control products
The EU project BIOCOMES started at the end of 2013 and aimed at the development of new biological control products. Now, at the end of the project, two new biological control products are...
No publications found
View all publications